The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Hill-Rom Holdings Inc

NYSE: HRC
Last

(U.S.) $45.76

Today's change-0.30 -0.65%
Updated November 28 1:02 PM EST. Delayed by at least 15 minutes.
 

Hill-Rom Holdings Inc

NYSE: HRC
Last

(U.S.) $45.76

Today's change-0.30 -0.65%
Updated November 28 1:02 PM EST. Delayed by at least 15 minutes.

Hill-Rom Holdings Inc down (U.S.)$0.30

Hill-Rom Holdings Inc closed lower Friday, dropping (U.S.)$0.30 or 0.65% to (U.S.)$45.76. Over the last five days, shares have gained 0.46% and are currently 1.14% off of the 52-week high. Shares have underperformed the S&P 500 by 4.51% during the last year.

Key company metrics

  • Open(U.S.) $46.07
  • Previous close(U.S.) $46.06
  • High(U.S.) $46.24
  • Low(U.S.) $45.66
  • Bid / Ask(U.S.) $41.67 / (U.S.) $49.79
  • YTD % change+10.69%
  • Volume210,794
  • Average volume (10-day)470,726
  • Average volume (1-month)498,778
  • Average volume (3-month)441,596
  • 52-week range(U.S.) $34.94 to (U.S.) $46.29
  • Beta1.35
  • Trailing P/E44.25×
  • P/E 1 year forward18.68×
  • Forward PEG1.53×
  • Indicated annual dividend(U.S.) $0.61
  • Dividend yield1.33%
  • Trailing EPS(U.S.) $1.03
Updated November 28 1:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.59%

Based on its net profit margin of 3.59%, Hill-Rom Holdings Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.75%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue480398415393
Total other revenue--------
Total revenue480398415393
Gross profit213187203177
Total cost of revenue267211213217
Total operating expense444360388372
Selling / general / administrative152129130138
Research & development22181616
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)53281
Other operating expenses, total--------
Operating income35382821
Interest income (expense), net non-operating-3-3-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax34362519
Income after tax2526-313
Income tax, total1010296
Net income2526-313
Total adjustments to net income--------
Net income before extra. items2526-313
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2526-313
Inc. avail. to common incl. extra. items2526-313
Diluted net income2526-313
Dilution adjustment--------
Diluted weighted average shares59585759
Diluted EPS excluding extraordinary itemsvalue per share0.420.45-0.060.22
Dividends per sharevalue per share0.150.150.150.14
Diluted normalized EPSvalue per share0.810.780.530.48